124 related articles for article (PubMed ID: 33974685)
21. Oral contraceptive use and cervical intraepithelial neoplasia.
Coker AL; McCann MF; Hulka BS; Walton LA
J Clin Epidemiol; 1992 Oct; 45(10):1111-8. PubMed ID: 1474407
[TBL] [Abstract][Full Text] [Related]
22. Different contraceptive practices: use of contraceptives in Finland and other Nordic countries in the 1970s and 1980s.
Makkonen K; Hemminki E
Scand J Soc Med; 1991 Mar; 19(1):32-8. PubMed ID: 1925424
[TBL] [Abstract][Full Text] [Related]
23. Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
Teklehaimanot DA; Mekuria AD; Dadi AF; Derseh BT
BMC Womens Health; 2024 May; 24(1):271. PubMed ID: 38702683
[TBL] [Abstract][Full Text] [Related]
24. Cervical cytology associated with levonorgestrel contraception.
Misra JS; Engineer AD; Tandon P
Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
[TBL] [Abstract][Full Text] [Related]
25. Pre-gravid oral contraceptive use and time to pregnancy: a Danish prospective cohort study.
Mikkelsen EM; Riis AH; Wise LA; Hatch EE; Rothman KJ; Sørensen HT
Hum Reprod; 2013 May; 28(5):1398-405. PubMed ID: 23427234
[TBL] [Abstract][Full Text] [Related]
26. The risk of cervical atypia in oral contraceptive users.
Adhikari I; Eriksson T; Luostarinen T; Lehtinen M; Apter D
Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):12-17. PubMed ID: 29412045
[TBL] [Abstract][Full Text] [Related]
27. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT.
Bahamondes MV; Espejo-Arce X; Bahamondes L
Hum Reprod; 2015 Aug; 30(8):1861-6. PubMed ID: 26040478
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study.
Larsen SV; Ozenne B; Köhler-Forsberg K; Poulsen AS; Dam VH; Svarer C; Knudsen GM; Jørgensen MB; Frokjaer VG
Front Endocrinol (Lausanne); 2022; 13():799675. PubMed ID: 35360055
[TBL] [Abstract][Full Text] [Related]
29. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use.
Kjaer SK; Engholm G; Dahl C; Bock JE; Lynge E; Jensen OM
Cancer Causes Control; 1993 Nov; 4(6):513-9. PubMed ID: 8280828
[TBL] [Abstract][Full Text] [Related]
30. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
Andrade AT; de Souza JP; Rowe PJ; Shaw ST
Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
[TBL] [Abstract][Full Text] [Related]
31. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
32. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
Kay CR
Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
[TBL] [Abstract][Full Text] [Related]
33. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.
Oddens BJ
Contraception; 1999 May; 59(5):277-86. PubMed ID: 10494480
[TBL] [Abstract][Full Text] [Related]
34. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
Skorstengaard M; Lynge E; Suhr J; Napolitano G
BJOG; 2020 May; 127(6):729-736. PubMed ID: 31880054
[TBL] [Abstract][Full Text] [Related]
35. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of endometriosis in women attending family planning clinics.
Vessey MP; Villard-Mackintosh L; Painter R
BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
[TBL] [Abstract][Full Text] [Related]
38. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention.
Dovey de la Cour C; Guleria S; Nygård M; Trygvadóttir L; Sigurdsson K; Liaw KL; Hortlund M; Lagheden C; Hansen BT; Munk C; Dillner J; Kjaer SK
Cancer Med; 2019 Feb; 8(2):839-849. PubMed ID: 30632704
[TBL] [Abstract][Full Text] [Related]
40. Improved utilization of spacing methods--intrauterine devices (IUDs) and low-dose combined oral contraceptives (OCs)--through re-orientation training for improving quality of services. Indian Council of Medical Research Task Force on IUD and Hormonal Contraceptives.
Contraception; 1994 Sep; 50(3):215-28. PubMed ID: 7805372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
